Digital Health Blue Earth and Siemens Partner for AI-Enhanced Prostate Imaging
Posluma and its Impact on Prostate Cancer Diagnosis Blue Earth Diagnostics, known for its trailblazing work in medical imaging, has introduced Posluma, a cutting-edge imaging agent significantly impacting prostate cancer diagnosis. This novel radiotracer, fluciclovine F-18, has been at the heart of
May 8, 2024